Eosmz, Mawachuwns
The enormous benefits of carry reperfusion using thrombolytic therapy have been demonstrated repeatedly in patients with ST segment elevation who develop Q wave myocardial infarction and are treated within 5 h of the onset of symptoms (l-4). Retrospective analyses of several individual trials (1,2) and a meta-analysis (5) have shown that thrombolytic therapy fails to improve clinical outCOme in patients wbo present with ST segment depression or develop non-Q wave myocardii infarction, or both. Thmmbolytic therapy is thought to be beneficial by achieving repemsion of occluded coronary arteries, wbicb are present in >9O?G of patients with acute myocardii infarction and ST segment elevation (6, 7) . In contrast, many triak have concluded that thmmbolysis is &&rive in patient% with myocardial infarction and ST segment depression or T wave inversion, or both, because in the majority of such patients the infarct-related artery is patent, albeit with a fknv-limiting stenosis (8, 9) . Because thmmbolytii tllkrapy has pmthmmbotic potential by activating platelets and exposing clot-bound thrombin, it is possible that in these patients the initially patent, stenosed coronary artery could pw to occlusion with thrombolytic therapy, as was suggested by the TIMI 111 trial (8,lO) . As a consequence, patients with ST segment depression, many of whom develop a non-Q wave infarction, who comprise almost 50% of all patients with acute myocardial '~farction, have been excluded from reperfnsion therapy. Another important group that has been excluded from therapy until recently are patients with ST segment elevation who present for treatment >6 h after the oMet of chest pain.
To determine whether eligiiility criteria for thrombolysk could be broadened, the Late Asessment of Thrombolytii Efficacy (LATE) trial (11) apy the large number of patients with ST segment elevation uhu presented between 6 and I? h after the onset of pain. Therefore. they embraced the results of the LATE trial (11) and the fiw trial overvieu (5) to whii the L&TE trial contributed. As 3 consequence, the eligiii for thrombolytic therapy of patients with ST segment eiaation was extended to thaw presenting as late as I2 !I after the onset of che5t pain.
The present rep NI by bagcr et al. (I?). based on subgroup analyses of LATE, some of them post hoc (i.e.. data derived), provides three major findings that are, respeai+.
1) interesting but not unexpected, 2) surprising. and 3) prrlvocati\e.
1. The interesting but not unexpected finding is that pa tients who developed a non-Q wave infarction experienced a lower mortality than those with a Q wave infarction. This observation is consistent with the idea that thmmhdytic therapy may prevent the evolution of non-Q wave into Q wave myocardial infarction because the wavefront of necmsis progressing from tbe subendxardium to the s&epicardium is interrupted by reperfusiin (13.14). It could be anticipated that patients in whom thromhdytic fberapy is socces&l in this regard also exhibit superior survival. II would be important IO ascertain tither the ditTerence in mortality between Q wave and ~91-4 wave infarctions was limited to those patients who received the thromboiytic therapy. 2. The surprising finding is that thrombolytic therapy did nol reduce mortality in patients with a myocardial infarction presenting with ST segment elevation. As pointed out before. many of these patients currently receive such treatment. based inpart(andperhapsmistakenly)ontheamch&msoftbe LNEtrial(ll).TberqmrtofLangeretal.(I2)qgeststhat a more detailed analysis of this patient group is needed to discca whether any subgroup of patients with ST segment eb&on benefit from thmmbolytic therapy XI h after the onset of symptoms. 3. llte pmvocative finding was that thromboh& therapy provided a substantial beneM in the subgroup of f&eats v;ith sTsegmentdrprrdon. Ifwecombinetheseadditionalana&softheLATEtrial with pmious, well established information, it would appear that thmmbotyk ttyapy is of benefit in patients with ST segment elmtion during the tint 6 h (but not later) and in patients with ST segment depessioa >6 h after the onset of symptoms(butnotearlier).Ihiipictun=i~puz.&ngandnot red!~fzx&wedbyestablkbed~~concepts.it issure!ynotinamcertwithcurrentpracGceinwhichthrombolytk therapy is adminktered 10 patients with a myocardiil infarctionwithSTe~tionupto12hafter~oosetofpain bntnottopatientswithsrsegrrreotdepresSoairrespmiveof 0731lW,%~ISsm FlJ slJn%lw7(%~1-4 BRAUNWALQ A?40 CANNON EDrnRlAi CoMrn thetimeaftertheorsetofchestpain.ff,assuggestedbyLanger et al (12) , thromboIytic therapy is beneficiaI in patients with ST seqentdepre&nwhoaretreated>6haftertheometof JymptomsisitIo&aItowithhoUitfrompaticntswithST segmentdepre&nwhocanhetreatedwithinthetkst6bours?
Patients with a myocartiai infarction with ST segment depression are heterogenecus, and it is possible that a sub groupperhaps thnse. with >2 mm ST segment depression, as suggested by Langer et al.+ benefited by thrombolytic therapy. It is not cIear in how many patients in the JAm trial the ST segment depresion was in anterior leads, which might act&y represent reciprocal electroxrdiographic changes from posteM ST elevation secondary to a totaIIy occluded circumfhzx corooaty artery. If improvement in outcome were limited to this partkuk subgroup of patients with ST segment depression, the Iindmgs of kmger et aI. may be consistent with :he current concept that thromboIysis is benelicial onIy in patients with some ST segment elevation.
Ilie interesting retrxpcctive subgroiip anaIyses of Langer et al. are of potential importance because the current treatment of patients with myocardiaI infarcticn and ST segment depresb Ieaws much to be desiied. These analyses should neither be d&missed simpIy because they do not fit current eonqta, nor shouId they form the basis for a sadden radiil akation in practice, such as using thromboIytic therapy in patients with acute myocardia! infarction and ST segment depression. Instead, they suggest that additional prospective, rigorously comkted trials of the role of thrombolytic t'lerapy in the care of this large segment of patients with acute nqvcardii infarction are warranted.
